227 related articles for article (PubMed ID: 34456212)
1. Considerations and guidance to control the rebound in COVID-19 cases.
Li Q; Zhan X; Wang J; Lu H
Biosci Trends; 2021 Nov; 15(5):341-344. PubMed ID: 34456212
[TBL] [Abstract][Full Text] [Related]
2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
3. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
[TBL] [Abstract][Full Text] [Related]
4. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
[TBL] [Abstract][Full Text] [Related]
5. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.
Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W
Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
7. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
Milne GJ; Carrivick J; Whyatt D
BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
[TBL] [Abstract][Full Text] [Related]
8. [Considerations on vaccines and immunization against COVID-19 for epidemic control in China].
Zhang Q; Wang FZ; Ma C; An ZJ; Yin ZD
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1371-1376. PubMed ID: 34963231
[TBL] [Abstract][Full Text] [Related]
9. Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
Shattock AJ; Le Rutte EA; Dünner RP; Sen S; Kelly SL; Chitnis N; Penny MA
Epidemics; 2022 Mar; 38():100535. PubMed ID: 34923396
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions.
Yang Q; Xiao X; Gu X; Liang D; Cao T; Mou J; Huang C; Chen L; Liu J
Int J Infect Dis; 2021 Apr; 105():442-447. PubMed ID: 33582375
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 on the Nile: Review on the Management and Outcomes of the COVID-19 Pandemic in the Arab Republic of Egypt from February to August 2020.
Gaye YE; Agbajogu C; El Oakley R
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567519
[TBL] [Abstract][Full Text] [Related]
12. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 imported cases and severity: expected information from genomic characterization of SARS-CoV-2 strains in Mozambique.
Sumbana J; Passanduca A; Rubino S
J Infect Dev Ctries; 2021 Dec; 15(12):1792-1800. PubMed ID: 35044934
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
[TBL] [Abstract][Full Text] [Related]
15. [Progress in research of epidemiologic feature and control of SARS-CoV-2 Delta variant].
Du M; Liu M; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1774-1779. PubMed ID: 34814611
[TBL] [Abstract][Full Text] [Related]
16. The stringency of the containment measures in response to COVID-19 inversely correlates with the overall disease occurrence over the epidemic wave.
Mezencev R; Klement C
Bratisl Lek Listy; 2022; 123(9):601-617. PubMed ID: 36039877
[TBL] [Abstract][Full Text] [Related]
17. Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan.
Shy CG; Lu JH; Lin HC; Hung MN; Chang HC; Lu ML; Chao HR; Chen YS; Wang PS
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162443
[TBL] [Abstract][Full Text] [Related]
18. The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam.
Thai PQ; Rabaa MA; Luong DH; Tan DQ; Quang TD; Quach HL; Hoang Thi NA; Dinh PC; Nghia ND; Tu TA; Quang N; Phuc TM; Chau V; Khanh NC; Anh DD; Duong TN; Thwaites G; van Doorn HR; Choisy M;
Clin Infect Dis; 2021 May; 72(9):e334-e342. PubMed ID: 32738143
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
[TBL] [Abstract][Full Text] [Related]
20. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
